HEADER TRANSFERASE/TRANSFERASE INHIBITOR 04-OCT-18 6MOB TITLE CRYSTAL STRUCTURE OF KIT1 IN COMPLEX WITH DP2976 VIA CO- TITLE 2 CRYSTALLIZATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 566-693,754-935; COMPND 5 SYNONYM: SCFR, PIEBALD TRAIT PROTEIN, PBT, PROTO-ONCOGENE C-KIT, COMPND 6 TYROSINE-PROTEIN KINASE KIT, P145 C-KIT, V-KIT HARDY-ZUCKERMAN 4 COMPND 7 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG; COMPND 8 EC: 2.7.10.1; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KIT, SCFR; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: TNIPRO; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PBACGUS KEYWDS DECIPHERA, KIT1 KINASE, DP2976, DECODE, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.E.EDWARDS,J.ABENDROTH,K.SAFFORD,L.CHUN REVDAT 3 03-APR-24 6MOB 1 REMARK REVDAT 2 13-MAR-24 6MOB 1 REMARK REVDAT 1 31-JUL-19 6MOB 0 JRNL AUTH B.D.SMITH,M.D.KAUFMAN,W.P.LU,A.GUPTA,C.B.LEARY,S.C.WISE, JRNL AUTH 2 T.J.RUTKOSKI,Y.M.AHN,G.AL-ANI,S.L.BULFER,T.M.CALDWELL, JRNL AUTH 3 L.CHUN,C.L.ENSINGER,M.M.HOOD,A.MCKINLEY,W.C.PATT, JRNL AUTH 4 R.RUIZ-SOTO,Y.SU,H.TELIKEPALLI,A.TOWN,B.A.TURNER,L.VOGETI, JRNL AUTH 5 S.VOGETI,K.YATES,F.JANKU,A.R.ABDUL RAZAK,O.ROSEN, JRNL AUTH 6 M.C.HEINRICH,D.L.FLYNN JRNL TITL RIPRETINIB (DCC-2618) IS A SWITCH CONTROL KINASE INHIBITOR JRNL TITL 2 OF A BROAD SPECTRUM OF ONCOGENIC AND DRUG-RESISTANT KIT AND JRNL TITL 3 PDGFRA VARIANTS. JRNL REF CANCER CELL V. 35 738 2019 JRNL REFN ISSN 1535-6108 JRNL PMID 31085175 JRNL DOI 10.1016/J.CCELL.2019.04.006 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 3 NUMBER OF REFLECTIONS : 43799 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.210 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2217 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.84 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3055 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.17 REMARK 3 BIN R VALUE (WORKING SET) : 0.2600 REMARK 3 BIN FREE R VALUE SET COUNT : 165 REMARK 3 BIN FREE R VALUE : 0.3050 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2412 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 89 REMARK 3 SOLVENT ATOMS : 311 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.35 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.09000 REMARK 3 B22 (A**2) : -0.09000 REMARK 3 B33 (A**2) : 0.18000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.104 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.102 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.065 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.064 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.951 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2639 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3581 ; 1.489 ; 1.999 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 334 ; 5.642 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 105 ;33.768 ;23.333 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 458 ;12.674 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 15 ;18.997 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 390 ; 0.113 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2011 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6MOB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-OCT-18. REMARK 100 THE DEPOSITION ID IS D_1000237316. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-SEP-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08ID-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : DCM WITH CRYO-COOLED 1ST CRYSTAL REMARK 200 SAGITTALLY BENT 2ND CRYSTAL REMARK 200 FOLLOWED BY VERTICALLY FOCUSING REMARK 200 MIRROR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-300 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43821 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : 0.05600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 24.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.4 REMARK 200 DATA REDUNDANCY IN SHELL : 4.90 REMARK 200 R MERGE FOR SHELL (I) : 0.49000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.520 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: BERYLLIUM, INTERNAL MODEL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12 MG/ML KIT1 PROTEIN IN 20 MM TRIS PH REMARK 280 8.0, 0.25 M SODIUM CHLORIDE, 5 MM IMIDAZOLE, 5 MM DTT, 1 MM EDTA, REMARK 280 CRYSTALLANT: 2.5 M AMMONIUM NITRATE, 0.1 M SODIUM ACETATE, PH REMARK 280 4.6, 5-FOLD MOLAR EXCESS DP2976, CRYSTAL ID 204905D1, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 72.51000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 40.34950 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 40.34950 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 108.76500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 40.34950 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 40.34950 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 36.25500 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 40.34950 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 40.34950 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 108.76500 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 40.34950 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 40.34950 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 36.25500 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 72.51000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2460 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15570 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 566 REMARK 465 SER A 931 REMARK 465 THR A 932 REMARK 465 ASN A 933 REMARK 465 HIS A 934 REMARK 465 ILE A 935 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 761 CG CD OE1 OE2 REMARK 470 GLU A 767 CG CD OE1 OE2 REMARK 470 ASN A 828 CG OD1 ND2 REMARK 470 LYS A 926 CG CD CE NZ REMARK 470 ILE A 928 CG1 CG2 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH2 ARG A 684 O HOH A 1101 2.02 REMARK 500 O HOH A 1102 O HOH A 1266 2.08 REMARK 500 O HOH A 1293 O HOH A 1340 2.13 REMARK 500 O3 NO3 A 1013 O HOH A 1102 2.14 REMARK 500 OD1 ASN A 649 O HOH A 1103 2.18 REMARK 500 NZ LYS A 642 O2 NO3 A 1005 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 THR A 694 C SER A 753 N 0.222 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 792 48.31 -149.77 REMARK 500 LEU A 813 17.39 58.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NO3 A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NO3 A 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NO3 A 1003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NO3 A 1004 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NO3 A 1005 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NO3 A 1006 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NO3 A 1007 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NO3 A 1008 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NO3 A 1009 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NO3 A 1010 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NO3 A 1011 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NO3 A 1012 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NO3 A 1013 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NO3 A 1014 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue JWY A 1015 DBREF 6MOB A 566 693 UNP P10721 KIT_HUMAN 566 693 DBREF 6MOB A 754 935 UNP P10721 KIT_HUMAN 754 935 SEQADV 6MOB THR A 694 UNP P10721 LINKER SEQADV 6MOB SER A 753 UNP P10721 LINKER SEQRES 1 A 312 ASN ASN TYR VAL TYR ILE ASP PRO THR GLN LEU PRO TYR SEQRES 2 A 312 ASP HIS LYS TRP GLU PHE PRO ARG ASN ARG LEU SER PHE SEQRES 3 A 312 GLY LYS THR LEU GLY ALA GLY ALA PHE GLY LYS VAL VAL SEQRES 4 A 312 GLU ALA THR ALA TYR GLY LEU ILE LYS SER ASP ALA ALA SEQRES 5 A 312 MET THR VAL ALA VAL LYS MET LEU LYS PRO SER ALA HIS SEQRES 6 A 312 LEU THR GLU ARG GLU ALA LEU MET SER GLU LEU LYS VAL SEQRES 7 A 312 LEU SER TYR LEU GLY ASN HIS MET ASN ILE VAL ASN LEU SEQRES 8 A 312 LEU GLY ALA CYS THR ILE GLY GLY PRO THR LEU VAL ILE SEQRES 9 A 312 THR GLU TYR CYS CYS TYR GLY ASP LEU LEU ASN PHE LEU SEQRES 10 A 312 ARG ARG LYS ARG ASP SER PHE ILE CYS SER LYS THR SER SEQRES 11 A 312 PRO ALA ILE MET GLU ASP ASP GLU LEU ALA LEU ASP LEU SEQRES 12 A 312 GLU ASP LEU LEU SER PHE SER TYR GLN VAL ALA LYS GLY SEQRES 13 A 312 MET ALA PHE LEU ALA SER LYS ASN CYS ILE HIS ARG ASP SEQRES 14 A 312 LEU ALA ALA ARG ASN ILE LEU LEU THR HIS GLY ARG ILE SEQRES 15 A 312 THR LYS ILE CYS ASP PHE GLY LEU ALA ARG ASP ILE LYS SEQRES 16 A 312 ASN ASP SER ASN TYR VAL VAL LYS GLY ASN ALA ARG LEU SEQRES 17 A 312 PRO VAL LYS TRP MET ALA PRO GLU SER ILE PHE ASN CYS SEQRES 18 A 312 VAL TYR THR PHE GLU SER ASP VAL TRP SER TYR GLY ILE SEQRES 19 A 312 PHE LEU TRP GLU LEU PHE SER LEU GLY SER SER PRO TYR SEQRES 20 A 312 PRO GLY MET PRO VAL ASP SER LYS PHE TYR LYS MET ILE SEQRES 21 A 312 LYS GLU GLY PHE ARG MET LEU SER PRO GLU HIS ALA PRO SEQRES 22 A 312 ALA GLU MET TYR ASP ILE MET LYS THR CYS TRP ASP ALA SEQRES 23 A 312 ASP PRO LEU LYS ARG PRO THR PHE LYS GLN ILE VAL GLN SEQRES 24 A 312 LEU ILE GLU LYS GLN ILE SER GLU SER THR ASN HIS ILE HET NO3 A1001 4 HET NO3 A1002 4 HET NO3 A1003 4 HET NO3 A1004 4 HET NO3 A1005 4 HET NO3 A1006 4 HET NO3 A1007 4 HET NO3 A1008 4 HET NO3 A1009 4 HET NO3 A1010 4 HET NO3 A1011 4 HET NO3 A1012 4 HET NO3 A1013 4 HET NO3 A1014 4 HET JWY A1015 33 HETNAM NO3 NITRATE ION HETNAM JWY N-{4-CHLORO-5-[1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2- HETNAM 2 JWY DIHYDRO-1,6-NAPHTHYRIDIN-3-YL]-2-FLUOROPHENYL}-N'- HETNAM 3 JWY PHENYLUREA FORMUL 2 NO3 14(N O3 1-) FORMUL 16 JWY C24 H21 CL F N5 O2 FORMUL 17 HOH *311(H2 O) HELIX 1 AA1 ASP A 572 LEU A 576 5 5 HELIX 2 AA2 ASP A 579 GLU A 583 5 5 HELIX 3 AA3 PRO A 585 ASN A 587 5 3 HELIX 4 AA4 HIS A 630 GLY A 648 1 19 HELIX 5 AA5 LEU A 678 ARG A 684 1 7 HELIX 6 AA6 LYS A 685 PHE A 689 5 5 HELIX 7 AA7 ASP A 765 LYS A 786 1 22 HELIX 8 AA8 ALA A 794 ARG A 796 5 3 HELIX 9 AA9 ASP A 816 ASP A 820 5 5 HELIX 10 AB1 PRO A 832 MET A 836 5 5 HELIX 11 AB2 ALA A 837 CYS A 844 1 8 HELIX 12 AB3 THR A 847 SER A 864 1 18 HELIX 13 AB4 ASP A 876 GLY A 886 1 11 HELIX 14 AB5 PRO A 896 TRP A 907 1 12 HELIX 15 AB6 ASP A 910 ARG A 914 5 5 HELIX 16 AB7 THR A 916 SER A 929 1 14 SHEET 1 AA1 5 LEU A 589 ALA A 597 0 SHEET 2 AA1 5 GLY A 601 TYR A 609 -1 O GLU A 605 N GLY A 592 SHEET 3 AA1 5 ALA A 617 LEU A 625 -1 O MET A 618 N ALA A 608 SHEET 4 AA1 5 LEU A 667 GLU A 671 -1 O VAL A 668 N LYS A 623 SHEET 5 AA1 5 LEU A 656 CYS A 660 -1 N GLY A 658 O ILE A 669 SHEET 1 AA2 3 GLY A 676 ASP A 677 0 SHEET 2 AA2 3 ILE A 798 THR A 801 -1 O LEU A 800 N GLY A 676 SHEET 3 AA2 3 ILE A 805 ILE A 808 -1 O LYS A 807 N LEU A 799 SHEET 1 AA3 2 VAL A 824 LYS A 826 0 SHEET 2 AA3 2 ALA A 829 LEU A 831 -1 O LEU A 831 N VAL A 824 SITE 1 AC1 6 ARG A 586 PHE A 591 PRO A 665 LEU A 667 SITE 2 AC1 6 HOH A1226 HOH A1274 SITE 1 AC2 4 ALA A 597 LYS A 602 LYS A 626 HOH A1184 SITE 1 AC3 8 GLY A 598 ALA A 599 PHE A 600 GLY A 601 SITE 2 AC3 8 LEU A 813 ARG A 815 HOH A1241 HOH A1250 SITE 1 AC4 4 ARG A 634 PRO A 665 THR A 666 HOH A1130 SITE 1 AC5 5 THR A 574 GLU A 635 MET A 638 SER A 639 SITE 2 AC5 5 LYS A 642 SITE 1 AC6 7 LYS A 581 TRP A 582 GLU A 583 PHE A 584 SITE 2 AC6 7 LEU A 657 GLY A 658 HOH A1142 SITE 1 AC7 7 LYS A 834 SER A 868 TYR A 870 PRO A 871 SITE 2 AC7 7 GLY A 872 MET A 873 HOH A1133 SITE 1 AC8 7 TYR A 675 PHE A 681 ARG A 684 LYS A 685 SITE 2 AC8 7 LEU A 762 ARG A 804 HOH A1108 SITE 1 AC9 5 ARG A 683 ARG A 686 GLY A 866 SER A 867 SITE 2 AC9 5 HOH A1139 SITE 1 AD1 6 TRP A 860 PRO A 871 MET A 889 LEU A 890 SITE 2 AD1 6 HOH A1118 HOH A1161 SITE 1 AD2 6 TYR A 870 MET A 873 MET A 882 ILE A 883 SITE 2 AD2 6 PHE A 887 ARG A 888 SITE 1 AD3 9 ASN A 587 ARG A 588 TYR A 609 PHE A 887 SITE 2 AD3 9 ARG A 888 HOH A1157 HOH A1159 HOH A1265 SITE 3 AD3 9 HOH A1304 SITE 1 AD4 5 LYS A 613 ALA A 616 ALA A 617 MET A 618 SITE 2 AD4 5 HOH A1102 SITE 1 AD5 3 ALA A 616 ALA A 617 GLU A 885 SITE 1 AD6 17 VAL A 603 ALA A 621 LYS A 623 GLU A 640 SITE 2 AD6 17 LEU A 644 ILE A 653 VAL A 654 VAL A 668 SITE 3 AD6 17 THR A 670 GLU A 671 CYS A 673 LEU A 799 SITE 4 AD6 17 ILE A 808 CYS A 809 ASP A 810 PHE A 811 SITE 5 AD6 17 HOH A1217 CRYST1 80.699 80.699 145.020 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012392 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012392 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006896 0.00000